American Century Companies’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-30,556
Closed -$88.3K – 2961
2026
Q1
$88.3K Buy
+30,556
New +$65.2K ﹤0.01% 2788
2025
Q2
– Sell
-39,525
Closed -$50.2K – 2907
2025
Q1
$50.2K Buy
39,525
+27,782
+237% +$72.6K ﹤0.01% 2863
2024
Q4
$38.2K Buy
+11,743
New +$42.3K ﹤0.01% 2877
2024
Q2
– Sell
-63,428
Closed -$934K – 2915
2024
Q1
$934K Buy
63,428
+12,062
+23% +$182K ﹤0.01% 2179
2023
Q4
$494K Buy
+51,366
New +$355K ﹤0.01% 2361
2023
Q3
– Sell
-11,088
Closed -$59.3K – 2878
2023
Q2
$59.3K Sell
11,088
-7,177
-39% -$44.3K ﹤0.01% 2754
2023
Q1
$130K Buy
18,265
+3,473
+23% +$20.9K ﹤0.01% 2503
2022
Q4
$99.3K Buy
+14,792
New +$81.1K ﹤0.01% 2456
2015
Q4
– Sell
-22,274
Closed -$477K – 1350
2015
Q3
$477K Buy
+22,274
New +$699K ﹤0.01% 1217

Other funds holding MGNX

American Century Companies's MGNX Position: Q2 2026 in Review

American Century Companies sold out of MacroGenics (MGNX) in Q2 2026, closing a stake of 30,556 shares — an estimated $88.3K sold.

American Century Companies first reported a position in MGNX in Q3 2015 and held it in 9 quarters. The position peaked at $934K in Q1 2024. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • American Century Companies reported no remaining MacroGenics position as of Q2 2026 after selling out during the quarter.
  • American Century Companies sold 30,556 MacroGenics shares in Q2 2026, an estimated $88.3K.
  • American Century Companies first reported a position in MacroGenics in Q3 2015 and held it in 9 quarters.
  • American Century Companies's MacroGenics position peaked at $934K in Q1 2024.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.